Annie,
Real patient. Individual
results may vary.
DUPIXENT was studied in a 16-week clinical trial with 251 patients* ages 12-17 with
moderate-to-severe eczema not adequately controlled with topical prescription treatments.
Results from a 16-week clinical trial of teens ages 12-17 with DUPIXENT when used alone compared to teens not taking DUPIXENT
The safety results of DUPIXENT observed in adolescents were consistent with what was seen in adults
with atopic dermatitis. The most common side effects include injection site reactions, eye and eyelid
inflammation, including redness, swelling, and itching, and cold sores in your mouth or on your lips.
*Patients who weighed ≥60 kg received DUPIXENT 300 mg every two weeks after an initial dose of 600 mg (two 300 mg injections),
and patients who weighed ≤60 kg received DUPIXENT 200 mg every two weeks after an initial dose of 400 mg (two 200 mg injections)
Expand the boxes below to see more detailed results from the clinical study with patients ages 12-17.
Results at 16 weeks when DUPIXENT was used alone compared to
patients ages 12-17 not taking DUPIXENT
24% of patients ages 12-17 had clear or almost clear skin compared to 2% not taking DUPIXENT
42% of patients ages 12-17 showed a 75% improvement in their skin compared to 8% not taking DUPIXENT
23% of patients ages 12-17 showed a 90% improvement in their skin compared to 2% not taking DUPIXENT
Patients ages 12-17 experienced a significant itch reduction as defined within the clinical trial
37% of patients ages 12-17 had significant itch reduction at 16 weeks when DUPIXENT was used alone compared to 5% not taking DUPIXENT
We were a little skeptical at first. Then, we noticed her skin clearing and improving over time. It was such a relief to find something that works for her.
- Yetunde, caregiver of Ore (pictured right),
teen patient taking DUPIXENT
Individual results may vary.
Yetunde and Ore’s StoryUse this Healthgrades™ tool to easily find nearby specialists with experience in treating children, teens, and adults with uncontrolled moderate-to-severe eczema (atopic dermatitis).
Subscribe to emails to get the latest news and information about DUPIXENT.
You'll receive the latest information in your email.
If you've been prescribed DUPIXENT, you can enroll in DUPIXENT MyWay with your doctor and get access to support resources like a personal Nurse Educator, supplemental injection support, and more.
